title: Role of belly board device in the age of intensity modulated radiotherapy for pelvic irradiation.
abstract: Small bowel dose often represents a limiting factor for radiation treatment of pelvic malignancies. To reduce small bowel toxicity, a belly board device (BBD) with a prone position is often recommended. Intensity modulated radiotherapy (IMRT) could reduce dose to small bowel based on the desired dose-volume constraints. We investigated the efficacy of BBD in conjunction with IMRT. A total of 11 consecutive patients with the diagnosis of rectal cancer, who were candidates for definitive therapy, were selected. Patients were immobilized with BBD in prone position for simulation and treatment. Supine position computed tomography (CT) data were either acquired at the same time or during a diagnostic scan, and if existed was used. Target volumes (TV) as well as organs at risk (OAR) were delineated in both studies. Three-dimensional conformal treatment (3DCRT) and IMRT plans were made for both scans. Thus for each patient, 4 plans were generated. Statistical analysis was conducted for maximum, minimum, and mean dose to each structure. When comparing the normalized mean Gross TV dose for the different plans, there was no statistical difference found between the planning types. There was a significant difference in small bowel sparing when using prone position on BBD comparing 3DCRT and IMRT plans, favoring IMRT with a 29.6% reduction in dose (p = 0.007). There was also a statistically significant difference in small bowel sparing when comparing supine position IMRT to prone-BBD IMRT favoring prone-BBD IMRT with a reduction of 30.3% (p = 0.002). For rectal cancer when small bowel could be a limiting factor, prone position using BBD along with IMRT provides the best sparing. We conclude that whenever a dose escalation in rectal cancer is desired where small bowel could be limiting factor, IMRT in conjunction with BBD should be selected.
authors.affiliation: Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN.
authors.forename: Neil C
authors.initials: NC
authors.lastname: Estabrook
authors.affiliation: Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN.
authors.forename: Gregory K
authors.initials: GK
authors.lastname: Bartlett
authors.affiliation: Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN.
authors.forename: Julia J
authors.initials: JJ
authors.lastname: Compton
authors.affiliation: Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN.
authors.forename: Higinia R
authors.initials: HR
authors.lastname: Cardenes
authors.affiliation: Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN; Department of Radiation Oncology, New York University Langone Medical Center, New York, NY. Electronic address: indra.das@nyumc.org.
authors.forename: Indra J
authors.initials: IJ
authors.lastname: Das
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D058958:Organs at Risk; D010388:Pelvis / Q000528:radiation effects*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D050397:Radiotherapy, Intensity-Modulated / Q000295:instrumentation*; D012004:Rectal Neoplasms / Q000532:radiotherapy*
keywords: Belly board device; IMRT; Rectal cancer; Small bowel toxicity